Dexamethasone versus neostigmine as an adjuvant to bupivcaine 0.25% for caudal analgesia in children undergoing open inguinal hernia repair

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201606001632982

Enrollment

Registered

2016-05-13

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery congenital inguinal hernia in children

Interventions

Group II ( bupivacaine ¿dexamethasone group):

Group I (bupivacaine group):

group III

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children aged 2-8 years, of either gender, ASA I-II, undergoing elective surgeries for inguinal hernia repair will be enrolled in the study.

Exclusion criteria

Exclusion criteria: Patients with the following conditions will excluded from the study: 1- Infection at the injection site. 2- coagulapathy 3-prexisting neurological diseases 4- Congenital anomalies 5- Allergy to one of the study drugs

Design outcomes

Primary

Measure	Time frame
the primary outcome of this study will be to compare the duration of postoperative analgesia of caudal block when dexamethasone and neostigmine will be added to bupivacaine 0.25% in children.	—

Secondary

Measure	Time frame
Secondary outcomes will be the hemodynamic stability and postoperative complications.	—

Countries

Egypt

Contacts

Public Contactshaimaa abd elkader

Lecturer of Anaesthesia and and Intesive care

shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026